BRPI0408518A - terapia combinada compreendendo nemorubicin e um inibidor de ciclooxigenase-2 - Google Patents

terapia combinada compreendendo nemorubicin e um inibidor de ciclooxigenase-2

Info

Publication number
BRPI0408518A
BRPI0408518A BRPI0408518-3A BRPI0408518A BRPI0408518A BR PI0408518 A BRPI0408518 A BR PI0408518A BR PI0408518 A BRPI0408518 A BR PI0408518A BR PI0408518 A BRPI0408518 A BR PI0408518A
Authority
BR
Brazil
Prior art keywords
inhibitor
nemorubicin
cyclooxygenase
combination therapy
cox
Prior art date
Application number
BRPI0408518-3A
Other languages
English (en)
Inventor
Maria Cristina Geroni
Maria Adele Pacciarini
Antonino Suarato
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of BRPI0408518A publication Critical patent/BRPI0408518A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"TERAPIA COMBINADA COMPREENDENDO NEMORUBICIN E UM INIBIDOR DE CICLOOXIGENASE-2". A presente invenção refere-se ao uso de um derivado de morfolinil antraciclina, um sal farmaceuticamente aceitável ou metabólito do mesmo, para a preparação de um medicamento em combinação com um inibidor de Cox-2, para uso simultâneo, separado ou seqüencial em tratamento de câncer, e a composições ou unidades embaladas compreendendo um derivado de morfolinil antraciclina e um inibidor de Cox-2.
BRPI0408518-3A 2003-03-18 2004-03-04 terapia combinada compreendendo nemorubicin e um inibidor de ciclooxigenase-2 BRPI0408518A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03075780 2003-03-18
PCT/EP2004/050251 WO2004082689A1 (en) 2003-03-18 2004-03-04 Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor

Publications (1)

Publication Number Publication Date
BRPI0408518A true BRPI0408518A (pt) 2006-03-07

Family

ID=33016930

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408518-3A BRPI0408518A (pt) 2003-03-18 2004-03-04 terapia combinada compreendendo nemorubicin e um inibidor de ciclooxigenase-2

Country Status (6)

Country Link
EP (1) EP1605951A1 (pt)
AU (1) AU2004222527A1 (pt)
BR (1) BRPI0408518A (pt)
CA (1) CA2519310A1 (pt)
MX (1) MXPA05009849A (pt)
WO (1) WO2004082689A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8742076B2 (en) 2008-02-01 2014-06-03 Genentech, Inc. Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
ES2655243T3 (es) 2008-04-11 2018-02-19 Tianjin Hemay Oncology Pharmaceutical Co., Ltd Derivados antibióticos de antraciclina con alta actividad, métodos de preparación y usos de los mismos
WO2009124468A1 (zh) * 2008-04-11 2009-10-15 天津和美生物技术有限公司 具有高活性的四环蒽醌类抗生素的衍生物及其制备和应用
CN102159248B (zh) 2008-07-15 2013-09-11 健泰科生物技术公司 蒽环类衍生物缀合物、它们的制备方法以及它们作为抗肿瘤化合物的用途
ES2533710T3 (es) 2010-12-02 2015-04-14 Nerviano Medical Sciences S.R.L. Proceso para la preparación de derivados de morfolinil antraciclina
WO2016040825A1 (en) 2014-09-12 2016-03-17 Genentech, Inc. Anthracycline disulfide intermediates, antibody-drug conjugates and methods
CN106999444B (zh) * 2014-10-03 2023-12-12 安吉尼科分子传输公司 完整的细菌衍生的囊泡对小分子化合物的增强装载

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0434960T3 (da) * 1989-12-19 1996-10-14 Pharmacia Spa Chirale 1,5-diiod-2-methoxy- eller benzyloxymellemprodukter
GB2296495B (en) * 1994-12-23 1998-04-15 Erba Carlo Spa Anthracycline derivatives
BR9916536A (pt) * 1998-12-23 2002-01-02 Searle & Co Método para o tratamento ou prevenção de um distúrbio de neoplasia em um mamìfero em necessidade deste tratamento ou prevenção, e, combinação
GB9909925D0 (en) * 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives

Also Published As

Publication number Publication date
CA2519310A1 (en) 2004-09-30
MXPA05009849A (es) 2005-12-06
WO2004082689A1 (en) 2004-09-30
AU2004222527A1 (en) 2004-09-30
EP1605951A1 (en) 2005-12-21

Similar Documents

Publication Publication Date Title
BRPI0415007A (pt) método para tratar, prevenir, modificar ou administrar dor, e, composição farmacêutica
BRPI0418029A (pt) formulação de anticorpos cd40 e métodos
BRPI0410503B8 (pt) composição tópica e uso da composição
BRPI0407897A (pt) derivados de cianopiridina úteis no tratamento de cáncer e outros distúrbios
WO2005120461A3 (en) Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
BRPI0608297A2 (pt) composições de lipossomos
AR051099A1 (es) Combinaciones terapeuticas que comprenden inhibidor de poli(adp-ribosa)polimerasas
AR034900A1 (es) Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica
MX2007006212A (es) Medicamento oral para liberacion modificada de al menos un principio activo bajo forma multimicrocapsular.
IL182352A0 (en) The use of et-743 in the preparation of a medicament for treating cancer and medical kits containing et-743
BR0316364A (pt) Combinação de terapia do câncer com um composto anticâncer ativado com gst e uma outra terapia anticâncer
BRPI0407234A (pt) Heterociclos substituìdos
WO2006050155A3 (en) Cancer therapeutic compositions
BRPI0413974A (pt) combinação, método de tratamento de cáncer em um animal de sangue quente, composição farmacêutica, e, uso de uma combinação
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
WO2006053049A3 (en) Herbal composition phy906 and its use in chemotherapy
MX2009011900A (es) Curacion de herida diabetica.
BRPI0511420A (pt) fosforodiamidatos de sulfoniletila
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
CO5640094A2 (es) Una composicion farmaceutica que comprende un antagonista del receptor p2x7 y un factor alfa de necrosis de tumor
BRPI0408518A (pt) terapia combinada compreendendo nemorubicin e um inibidor de ciclooxigenase-2
WO2004014367A3 (en) Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer's disease
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
BR0206819A (pt) Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]